Mirta García
Hospital Universitario Miguel Servet(ES)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study(2018)17 cited
- → Fibrilación ventricular tras la administración de succinilcolina(2007)2 cited
- → MERIBEL study: Single-agent eribulin as first-line therapy for taxane-resistant HER2[-] metastatic breast cancer (MBC) patients (pts)(2016)1 cited
- → Neoadjuvant biweekly dose-dense chemotherapy with fluouracil, epirubicin, and cyclophosphamide (FEC 90), followed by docetaxel in patients with HER2-neu negative primary breast cancer(2009)1 cited
- → Enfermedad celíaca y neuromielitis óptica: una rara pero posible relación(2017)1 cited
- Docencia en Ingeniería Acústica(2009)
- → Abstract OT2-2-03: MERIBEL study: Efficacy of eribulin in first line of taxane-resistant patients with HER2 negative metastatic breast cancer(2015)
- → Abstract P1-08-36: Neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER). Analysis of biomarkers(2013)
- → Association of Inflammatory Profile and Postoperative Outcomes in Patients Undergoing Thoracic Surgery for Suspected Lung Cancer(2025)